(8AR,11AR)-9H-4,5,6,7,8A,10,11,11A-八氢环戊并[4,5]吡咯并[3,2,1-JK][1,4]苯并二氮杂卓 | 428868-32-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: (8AR,11AR)-9H-4,5,6,7,8A,10,11,11A-八氢环戊并[4,5]吡咯并[3,2,1-JK][1,4]苯并二氮杂卓
• 英文名称: (7bR,10aR)-2,3,4,7b,8,9,10,10a-Octahydro-1H-cyclopenta[b][1,4]diazepino[6,7,1-hi]indole
• 英文别名: (11R,15R)-7,10-diazatetracyclo[8.5.1.05,16.011,15]hexadeca-1,3,5(16)-triene
• CAS: 428868-32-0
• 化学式: C₁₄H₁₈N₂
• 分子量: 214.31
• InChiKey: XOSKJKGKWRIMGV-DGCLKSJQSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  16
• 可旋转键数：
  0
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.57
• 拓扑面积：
  15.3
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• [EN] CYCLOPROPYLMETHANAMINES AS SELECTIVE 5-HT(2C) RECEPTOR AGONISTS<br/>[FR] CYCLOPROPYLMÉTHANAMINES UTILISÉES COMME AGONISTES SÉLECTIFS DES RÉCEPTEURS 5-HT(2C)
  申请人：UNIV ILLINOIS

  公开号：WO2016123164A1

  公开（公告）日：2016-08-04

  Disclosed are 2-phenyl-cyclopropylmethanamines which are selective 5-HT(2C) receptor agonists and are used in the treatments of diseases and conditions wherein modulation of 5-HT(2C) receptors provides a benefit, such as obesity and psychiatric disorders.

  揭示了一种选择性5-HT(2C)受体激动剂2-苯基环丙基甲胺，用于治疗疾病和病况，其中调节5-HT(2C)受体能够带来益处，如肥胖和精神障碍。
• Processes for preparation of cyclopenta [b] [1,4] diazepino [6,7,1-hi] indoles and derivatives
  申请人：American Home Products Corporation

  公开号：US20020062022A1

  公开（公告）日：2002-05-23

  This invention provides processes for synthesizing compounds of formula I: 1 wherein R is H or alkyl; R 1 , R 2 are H, alkyl, alkoxy, halogen, fluorinated alkyl, —CN, alkyl sulfonamide, alkyl amide, amino, alkylamino, dialkylamino, fluorinated alkoxy, acyl, or aroyl; R 3 and R 4 are H, alkyl or cycloalkyl; the dashed line indicates an optional double bond; as well as intermediates and pharmaceutically acceptable salts thereof.

  本发明提供了合成式I的化合物的方法：其中R为H或烷基；R1，R2为H，烷基，烷氧基，卤素，氟化烷基，-CN，烷基磺酰胺，烷基酰胺，氨基，烷基氨基，二烷基氨基，氟化烷氧基，酰基或芳酰基；R3和R4为H，烷基或环烷基；虚线表示可选的双键；以及其中间体和药学上可接受的盐。
• Cyclopenta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives
  申请人：Sabb Louise Annmarie

  公开号：US20050004101A1

  公开（公告）日：2005-01-06

  This invention provides compounds of the formulae: wherein: R 1 is hydrogen, —C(O)CH 3 or alkyl of 1-6 carbon atoms; R 2 and R 3 are each, independently, hydrogen, alkyl of 1-6 carbon atoms, cycloalkyl, alkoxy of 1-6 carbon atoms, —CH 2 OH, fluoroalkyl, alkyl sulfonamide of 1-6 carbon atoms, alkyl amide of 1-6 carbon atoms, amino, alkylamino of 1-6 carbon atoms, dialkylamino of 1-6 carbon atoms per alkyl moiety, fluoroalkoxy of 1-6 carbon atoms, acyl of 2-7 carbon atoms, aryl, or aroyl; R 4 and R 5 are each, independently, hydrogen, alkyl of 1-6 carbon atoms, alkoxy of 1-6 carbon atoms, halogen, fluoroalkyl, —CN, alkyl sulfonamide of 1-6 carbon atoms, alkyl amide of 1-6 carbon atoms, amino, alkylamino of 1-6 carbon atoms, dialkylamino of 1-6 carbon atoms per alkyl moiety, fluoroalkoxy of 1-6 carbon atoms, acyl of 2-7 carbon atoms, or aroyl; R 6 and R 7 are each independently hydrogen, C 1 -C 6 alkyl or cycloalkyl; or a pharmaceutically acceptable salt thereof, as well as pharmaceutical compositions containing these compounds and methods for their use, including treatment of obsessive-compulsive disorder, panic disorder, depression, anxiety, generalized anxiety disorder, schizophrenia, migraine, sleep disorders, eating disorders, obesity, epilepsy, and spinal cord injury.

  本发明提供了以下式的化合物：其中：R1是氢，—C（O）CH3或1-6碳原子的烷基；R2和R3各自独立地是氢、1-6碳原子的烷基、环烷基、1-6碳原子的烷氧基、—CH2OH、氟代烷基、1-6碳原子的烷基磺酰胺、1-6碳原子的烷基酰胺、氨基、1-6碳原子的烷基氨基、每个烷基基团的1-6碳原子的二烷基氨基、1-6碳原子的氟代烷氧基、2-7碳原子的酰基、芳基或芳酰基；R4和R5各自独立地是氢、1-6碳原子的烷基、1-6碳原子的烷氧基、卤素、氟代烷基、—CN、1-6碳原子的烷基磺酰胺、1-6碳原子的烷基酰胺、氨基、1-6碳原子的烷基氨基、每个烷基基团的1-6碳原子的二烷基氨基、1-6碳原子的氟代烷氧基、2-7碳原子的酰基或芳酰基；R6和R7各自独立地是氢、C1-C6烷基或环烷基；或其药学上可接受的盐，以及含有这些化合物的制药组合物和它们的使用方法，包括治疗强迫症、惊恐障碍、抑郁症、焦虑、广泛性焦虑障碍、精神分裂症、偏头痛、睡眠障碍、进食障碍、肥胖症、癫痫和脊髓损伤。
• Fused heterocyclic compound and use thereof
  申请人：Shirai Junya

  公开号：US20090131402A1

  公开（公告）日：2009-05-21

  The present invention relates to a serotonin 5-HT 2C receptor activator containing a compound represented by the formula wherein ring A is a 5- or 6-membered aromatic heterocycle optionally having substituent(s), and ring B is a 7- to 9-membered ring optionally having substituent(s) other than an oxo group wherein the combination of m and n (m,n) is (1,2), (2,1), (2,2), (3,1), (3,2) or (4,1), or a salt thereof or a prodrug thereof, and a fused heterocyclic compound having a serotonin 5-HT 2C receptor activating action and the like.

  本发明涉及一种含有化合物的5-羟色胺5-HT2C受体激动剂，所述化合物的结构式为：其中，环A是一种5-或6-成员的芳香杂环，可选地具有取代基；环B是一种7-至9-成员的环，可选地具有除氧基以外的取代基，其中m和n（m，n）的组合为（1，2）、（2，1）、（2，2）、（3，1）、（3，2）或（4，1），或其盐或前药，以及具有5-羟色胺5-HT2C受体激活作用等的融合杂环化合物。
• CYCLOPENTA[b][1,4]DIAZEPINO[6,7,1-hi]INDOLES AND DERIVATIVES
  申请人：Sabb Louise Annmarie

  公开号：US20080009480A1

  公开（公告）日：2008-01-10

  This invention provides compounds of the formulae: wherein: R 1 is hydrogen, —C(O)CH 3 or alkyl of 1-6 carbon atoms; R 2 and R 3 are each, independently, hydrogen, alkyl of 1-6 carbon atoms, cycloalkyl, alkoxy of 1-6 carbon atoms, —CH 2 OH, fluoroalkyl, alkyl sulfonamide of 1-6 carbon atoms, alkyl amide of 1-6 carbon atoms, amino, alkylamino of 1-6 carbon atoms, dialkylamino of 1-6 carbon atoms per alkyl moiety, fluoroalkoxy of 1-6 carbon atoms, acyl of 2-7 carbon atoms, aryl, or aroyl; R 4 and R 5 are each, independently, hydrogen, alkyl of 1-6 carbon atoms, alkoxy of 1-6 carbon atoms, halogen, fluoroalkyl, —CN, alkyl sulfonamide of 1-6 carbon atoms, alkyl amide of 1-6 carbon atoms, amino, alkylamino of 1-6 carbon atoms, dialkylamino of 1-6 carbon atoms per alkyl moiety, fluoroalkoxy of 1-6 carbon atoms, acyl of 2-7 carbon atoms, or aroyl; R 6 and R 7 are each independently hydrogen, C 1 -C 6 alkyl or cycloalkyl; or a pharmaceutically acceptable salt thereof, as well as pharmaceutical compositions containing these compounds and methods for their use, including treatment of obsessive-compulsive disorder, panic disorder, depression, anxiety, generalized anxiety disorder, schizophrenia, migraine, sleep disorders, eating disorders, obesity, epilepsy, and spinal cord injury.

  这项发明提供了以下式子的化合物：其中：R1为氢、—C（O）CH3或1-6个碳原子的烷基；R2和R3各自独立地为氢、1-6个碳原子的烷基、环烷基、1-6个碳原子的烷氧基、—CH2OH、氟代烷基、1-6个碳原子的烷基磺酰胺、1-6个碳原子的烷基酰胺、氨基、1-6个碳原子的烷基氨基、每个烷基成分的1-6个碳原子的双烷基氨基、1-6个碳原子的氟代烷氧基、2-7个碳原子的酰基、芳基或芳酰基；R4和R5各自独立地为氢、1-6个碳原子的烷基、1-6个碳原子的烷氧基、卤素、氟代烷基、—CN、1-6个碳原子的烷基磺酰胺、1-6个碳原子的烷基酰胺、氨基、1-6个碳原子的烷基氨基、每个烷基成分的1-6个碳原子的双烷基氨基、1-6个碳原子的氟代烷氧基、2-7个碳原子的酰基或芳酰基；R6和R7各自独立地为氢、C1-C6烷基或环烷基；或其药学上可接受的盐，以及包含这些化合物的制药组合物和它们的使用方法，包括治疗强迫症、恐慌症、抑郁症、焦虑症、广泛性焦虑症、精神分裂症、偏头痛、睡眠障碍、进食障碍、肥胖症、癫痫和脊髓损伤。